BIOMAT Database Logo BIOMAT Database Logo

Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. 1996

F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Rhône-Poulenc Rorer, Centre de Recherche de Vitry-Alfortville, Vitry sur Seine, France.

A novel series of omega-aminoalkanoic acid derivatives of betulinic acid were synthesized and evaluated for their activity against human immunodeficiency virus (HIV). The anti-HIV-1 activity of several members of this new series was found to be in the nanomolar range in CEM 4 and MT-4 cell cultures. The optimization of the omega-aminoalkanoic acid side chain is described. The presence of an amide function within the side chain was found important for optimal activity. RPR 103611 (14g), a statine derivative, was found to be inactive against HIV-1 protease, reverse transcriptase, and integrase as well as on gp120/CD4 binding. "Time of addition" experiments suggested interaction with an early step of HIV-1 replication. As syncytium formation, but not virus-cell binding, seems to be affected, betulinic acid derivatives are assumed to interact with the postbinding virus-cell fusion process.

UI MeSH Term Description Entries
D004254 DNA Nucleotidyltransferases Enzymes that catalyze the incorporation of deoxyribonucleotides into a chain of DNA. EC 2.7.7.-. Nucleotidyltransferases, DNA
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000094062 Betulinic Acid A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities. 3-Epi-betulinic Acid,3-Hydroxy-lup-20(29)-en-28-oic Acid,3-Hydroxylup-20(29)-en-28-oic Acid,Betulic Acid,3 Epi betulinic Acid
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.
March 2013, Journal of medicinal chemistry,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
December 2009, Journal of medicinal chemistry,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.
August 1994, Antiviral research,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Oxoquinoline acyclonucleoside phosphonate analogues as a new class of specific inhibitors of human immunodeficiency virus type 1.
August 2012, Bioorganic & medicinal chemistry letters,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.
December 2012, Viruses,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
January 2008, Antimicrobial agents and chemotherapy,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
August 1991, Proceedings of the National Academy of Sciences of the United States of America,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors.
February 1997, Antimicrobial agents and chemotherapy,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
November 1995, Journal of medicinal chemistry,
F Soler, and C Poujade, and M Evers, and J C Carry, and Y Hénin, and A Bousseau, and T Huet, and R Pauwels, and E De Clercq, and J F Mayaux, and J B Le Pecq, and N Dereu
Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
June 1992, Antiviral research,
Copied contents to your clipboard!